ALT earnings: a negative outcome, -8.2%

On March 15, 2022, Altimmune, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.2% in the window around the event. It had already run -9.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.